CervoMed (CRVO) vs Serina Therapeutics (SER)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CervoMed (CRVO) has outperformed Serina Therapeutics (SER) over the past year, losing 62.7% versus a loss of 62.8%. Over five years, CRVO leads with a -91.2% price change compared with -93.9% for SER. Serina Therapeutics is the larger company by market cap ($51.1 million vs $49.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRVO | SER |
|---|---|---|
| Share price | $3.25 | $2.01 |
| Market cap | $49.06M | $51.08M |
| 1-day change | +2.04% | -0.22% |
| YTD return | -59.75% | +5.07% |
| 1-year return | -62.72% | -62.78% |
| 5-year return | -91.17% | -93.88% |
| EPS (TTM) | $-3.21 | $-1.87 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.00 | $5.71 |
| 52-week low | $2.13 | $1.22 |
| Distance from 52-week high | -67.55% | -64.79% |
| Average volume | 339.98K | 64.02K |
| Shares outstanding | 15.12M | 25.40M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CRVO vs SER FAQ
Which is bigger, CervoMed or Serina Therapeutics?
Serina Therapeutics (SER) is larger, with a market capitalization of $51.08M compared with $49.06M for CervoMed (CRVO).
Which stock has performed better over the past year, CRVO or SER?
CRVO returned -62.72% over the past 12 months, compared with -62.78% for SER (price return, excluding dividends). Past performance does not predict future results.
Are CervoMed and Serina Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.